Venturini et al. BMC Infectious Diseases 2014, 14(Suppl 1):S5 http://www.biomedcentral.com/1471-2334/14/S1/S5
PLOS ONE | www.plosone.org 1
January 2014 | Volume 9 | Issue 1 | e86616
PLoS One. 2012; 7(4): e29656.
Published online 2012 Apr 20. doi: 10.1371/journal.pone.0029656
PLoS ONE 9(1): e87262. doi:10.1371/journal.pone.0087262
retard mental, est définie comme un arrêt du développement mental ou un développement mental
incomplet, caractérisé essentiellement par une insuffisance des facultés qui déterminent
le niveau global d’intelligence, c’est-à-dire les fonctions cognitives, le langage, la motricité
et l...es performances sociales (Organisation Mondiale de la Santé, OMS, 1992).
more
Cette première édition de LNME constitue un grand pas dans la mise en oeuvre de la Politique Pharmaceutique Nationale. Le MSPP, à travers la Direction de la Pharmacie, du Médicament et de la Médecine Traditionnelle, s’engage à mettre à jour la présente Liste Nationale de Médicaments Essen...tiels tous les deux ans et compte sur la participation de tous les professionnels de santé et autres parties prenantes.
more
Research Article
Hindawi Publishing Corporation
AIDS Research and Treatment
Volume 2011, Article ID 621078, 7 pages doi:10.1155/2011/621078
Anxiety disorders
Chapter F.2
Целью этой главы является представление ключевых элементов, касающихся терапевтического использования психотропных лекарственных средств у детей и подростков, ... также знакомство
клиницистов с общими принципами фармакотерапии психиатрических расстройств в период развития. Для более детального ознакомления со специфическими медикаментами мы рекомендуем читателям обратиться к соответствующим главам, посвященным конкретным расстройствам.
more
The Journal of Infection in Developing Countries 7(3):289-292
International Development vol. 11. DOI 10.4073/csr.2015.15
Antimicrobial Resistance and Infection Control 2014,3 :31
PLoS Pathogens | www.plospathogens.org 1
February 2012 | Volume 8 | Issue 2 | e100246
Cognitive deficits in schizophrenia can massively impact functionality and quality of life, furthering the importance of cognitive training. Despite the development of the field in Europe and in the United States, no programmes have been developed and tested in developing countries. Different cultur...al backgrounds, budget restrictions, and other difficulties may render treatment packages created in high income countries difficult for adoption by developing nations. We performed a pilot double-blind, randomized, controlled trial in order to investigate the efficacy and feasibility of an attention and memory training programme specially created in
a developing nation. The intervention used simple, widely available materials, required minimal infrastructure, and was conducted in groups.The sample included seventeen stable Brazilians with schizophrenia. Sessions were conducted weekly during five months. The cognitive training group showed significant improvements in inhibitory control and set-shifting over time. Both groups showed improvements in symptoms, processing speed, selective attention, executive function, and long-term visual memory. Improvements were found in the control group in long-term verbal memory and concentration. Our findings reinforce the idea that cognitive training in schizophrenia can be constructed using simple resources and infrastructure, facilitating its adoption by developing countries, and it may improve cognition.
more
Joint United Nations Programme on HIV/AIDS (UNAIDS).
2014/HS S1 | pages 35 à 38
ISSN 0995-3914
Nurses' perceptions about providing spiritual care